Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Renalytix American Depository Receipt RNLXY

Healthcare Medical Devices
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. The Company’s lead product, KidneyIntelX... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCQB:RNLXY)

Renalytix plc Reports Financial Results for First Quarter of Fiscal Year 2025

PR Newswire 3 days ago

Commencement of trading on OTCQB in the United States

GlobeNewswire October 8, 2024

Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US

GlobeNewswire July 11, 2024

Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination

GlobeNewswire June 27, 2024

Medicare Issues Final Coverage Determination for kidneyintelX.dkd

GlobeNewswire June 14, 2024

Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024

GlobeNewswire May 15, 2024

Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15

GlobeNewswire May 9, 2024

Renalytix Announces Financing with Expected Size of up to $4 Million

GlobeNewswire April 8, 2024

KidneyIntelX(TM) included in Final KDIGO 2024 Clinical Guideline for Chronic Kidney Disease (CKD)

GlobeNewswire March 14, 2024
View More News ››

Opinion & Analysis (OTCQB:RNLXY)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCQB:RNLXY)

Renalytix plc (RNLX): Pioneering Precision Medicine for Chro

http://beyondspx.com/2024/08/02/renalytix-plc-rnlx-pioneering-precision-medicine-for-chronic-kidney-disease/
MikeTester - August 3, 2024

Medicare Issues Final Coverage Determination for kidneyintel

Just In: $RNLX Medicare Issues Final Coverage Determination for kidneyintelX.dkdLONDON&#xA0;and&#xA0;NEW YORK, June 14, 2024...
whytestocks - June 14, 2024

Why Is AI-Powered Diagnostic Firm Renalytix Stock Soaring On

JUST IN: $RNLX Why Is AI-Powered Diagnostic Firm Renalytix Stock Soaring On Monday? | BenzingaRenalytix plc@(NASDAQ:RNLX) has received...
whytestocks - March 4, 2024

RNLX.....Halt #4

Dilution pump...probably
Iseneschal - February 12, 2024
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. is a Canada-based company, which is focused exploration and development property bank which ...
View More »